ACSBG1‑driven lipid reprogramming unveiled: A fatty acid metabolism‑associated prognostic model for lung adenocarcinoma
Oncology Reports · 27.02.2026 · 55 (5) · 1-12
DOI: 10.3892/or.2026.9087 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 27.02.2026. Verfasst von Panxin Hu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, The First People's Hospital of Taizhou, Taizhou, Zhejiang 318020, P.R. China. Hauptthemen laut MEDLINE: Fatty Acids, Adenocarcinoma of Lung, Lung Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Medicine, The First People's Hospital of Taizhou, Taizhou, Zhejiang 318020, P.R. China.
- Department of Cardiothoracic Surgery, The First People's Hospital of Taizhou, Taizhou, Zhejiang 318020, P.R. China.
Zitieren
APA
Hu, P., & Li, A. (2026). ACSBG1‑driven lipid reprogramming unveiled: A fatty acid metabolism‑associated prognostic model for lung adenocarcinoma. Oncology Reports, 55(5), 1-12. https://doi.org/10.3892/or.2026.9087
Vancouver
Hu P, Li A. ACSBG1‑driven lipid reprogramming unveiled: A fatty acid metabolism‑associated prognostic model for lung adenocarcinoma. Oncology Reports. 2026;55(5):1-12. doi:10.3892/or.2026.9087
BibTeX
@article{Hu2026,
author = {Hu, Panxin and Li, Anan},
title = {ACSBG1‑driven lipid reprogramming unveiled: A fatty acid metabolism‑associated prognostic model for lung adenocarcinoma},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {5},
pages = {1--12},
doi = {10.3892/or.2026.9087}
}
EUVIMED